Apolipoprotein A and biological half-life of prostaglandin I 2 in HIV-1 infection

Author： Pirich C.   Efthimiou Y.   O'Grady J.   Zielinski C.   Sinzinger H.  

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.81, Iss.2, 1996-01, pp. : 213-218

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Elimination Half-Life May Explain the Relative Efficacy of Boceprevir and Telaprevir in the Treatment of Hepatitis C Virus Genotype 1

By Calcagno Andrea   Boglione Lucio   De Rosa Francesco Giuseppe   Di Perri Giovanni   Bonora Stefano  

Clinical Infectious Diseases, Vol. 56, Iss. 11, 2013-06 ,pp. : 1677-1678

Oxford University Press

Access to resources Recommend Favorite

HYPERALPHALIPOPROTEINEMIA AND PROSTAGLANDIN I 2 STABILITY

By Pirich C.   Efthimiou Y.   O'Grady J.   Sinzinger H.  

Thrombosis Research, Vol. 88, Iss. 1, 1997-10 ,pp. : 41-49

Elsevier

Access to resources Recommend Favorite

HIV-1 Variable Loop 2 and its Importance in HIV-1 Infection and Vaccine Development

By  

Current HIV Research, Vol. 11, Iss. 5, 2013-07 ,pp. : 427-438

Bentham Science Publishers

Access to resources Recommend Favorite

Dual infection with HIV-1 and HIV-2: double trouble or destructive interference?

By de Silva Thushan I   van Tienen Carla   Rowland-Jones Sarah L   Cotten Matthew  

HIV Therapy, Vol. 4, Iss. 3, 2010-05 ,pp. : 305-323

Future Medicine

Access to resources Recommend Favorite

Serum Apolipoprotein-A1 and Cholesterol Levels in Nigerian Children with Plasmodium falciparum Infection

By  

Medical Principles and Practice, Vol. 24, Iss. 4, 2015-05 ,pp. : 318-324

Karger

Access to resources Recommend Favorite